Federico Grossi - Feb 23, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ David Watson, attorney-in-fact for Dr. Federico Grossi
Stock symbol
APLS
Transactions as of
Feb 23, 2022
Transactions value $
$17,671
Form type
4
Date filed
2/24/2022, 03:33 PM
Previous filing
Feb 16, 2022
Next filing
Mar 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $17.7K +4.1K +3.86% $4.31* 110K Feb 23, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -4.1K -6.63% $0.00 57.7K Feb 23, 2022 Common Stock 4.1K $4.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option was granted on 08/21/2017 and is fully vested.